Vimarsana
Biggest News Aggregation in the World

Harry Steenbock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harry Steenbock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harry Steenbock Today - Breaking & Trending Today

How Much Vitamin D Do You Need to Stay Healthy? | Scientific American - Vimarsana News

How Much Vitamin D Do You Need to Stay Healthy? | Scientific American

Most people naturally have good vitamin D levels. Overhyped claims that the compound helps to fight diseases from cancer to depression aren’t borne out by recent research

Medicine must be freed from the vise grip of patent law - Vimarsana News

Medicine must be freed from the vise grip of patent law

New drugs are developed with vast amounts of taxpayer money. But instead of universal access to these publicly funded scientific achievements, we get prohibitively expensive medicine and sky-high profits for pharmaceutical companies.

UMass Amherst chancellor finalist Paul Tikalsky visits from Oklahoma State University - Vimarsana News

UMass Amherst chancellor finalist Paul Tikalsky visits from Oklahoma State University

AMHERST — Should Paul Tikalsky be selected as the next chancellor for the University of Massachusetts Amherst, he would strive to continue the campus’s growing reputation for academic excellence.“You don’t have to rebuild anything,” Tikalsky said...

Medicine Must Be Freed From the Vise Grip of Patent Law – The Wire Science - Vimarsana News

Medicine Must Be Freed From the Vise Grip of Patent Law – The Wire Science

We can't depend on monopolies to deliver the medicines we need.

Could a fix on drug prices harm university ag tech-transfers? - Vimarsana News

Could a fix on drug prices harm university ag tech-transfers?

University of Wisconsin-Madison researchers point to worries about their funding source if they can’t control income from royalties, if the federal government gets too aggressive in disrupting research deals and drug pricing.

Source: agweek.com